IJCEMR

Article http://dx.doi.org/10.26855/ijcemr.2025.01.010

A Case Report and Literature Review of a 33-year-old Female with Youthful RS3PE Syndrome

TOTAL VIEWS: 781

Chan Cai, Yinghua Li*, Mammillan, Rong Yang, Yunchun Zhou

Department of General Medicine, Yuxi People's Hospital, Yuxi 653100, Yunnan, China.

*Corresponding author: Yinghua Li

Published: February 25,2025

Abstract

This paper presents the clinical diagnosis and management of a 33-year-old female diagnosed with young-onset RS3PE syndrome. The patient received appropriate treatment and was subsequently discharged from the Department of General Practice. She has been recovering well and has undergone continuous follow-up for six months without any recurrence. RS3PE syndrome is predominantly observed in elderly males, making it challenging to differentiate from other rheumatic immune disorders during clinical diagnosis. Additionally, it has been associated with tumor development. Currently, there is a lack of consensus both domestically and internationally regarding its pathogenesis, treatment, and diagnostic gold standard. Due to the limited sample sizes and short durations of existing studies, clinicians often exhibit habitual thinking patterns when diagnosing and treating such rare cases, leading to potential misdiagnosis. Consequently, it is essential to conduct necessary aux-iliary examinations to gather additional diagnostic information, facilitate early differential diagnosis, enhance prognosis, and improve the quality of life for patients.

References

[1] McCarty DJ. Remitting seronegative symmetrical synovitis with pitting edema-reply. JAMA. 1986;255(18):2444.

[2] Wang LF, Liu W, Dong P, Song H. The value of anti-osteoporosis therapy in patients with mild seronegative symmetric synovitis with depressed edema syndrome. Chinese Journal of Rheumatology. 2020;24(12):3.

[3] Gago IA, Vicente López O, Pérez Alonso-Castrillo M. RS3PE: A presentation of a case. Atencion Primaria. 2021;53(3):101978.

[4] McCarty DJ, O'Duffy JD. Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA. 1985;254(19):2763-2767.

[5] Kyotani M, Kenzaka T, Nishio R, Akita H. RS3PE syndrome developing during the course of probable toxic shock syndrome: A case report. BMC Infectious Diseases. 2018;18(1):174.

[6] Zhu X, Xu D, Zeng X, Gu J, Zhou J, Wu H, et al. Clinical management of gout. Chinese Journal of Internal Medicine. 2021;60(3):6.

[7] Wang W, Wang HR, Li W, Wang R. Experience in the treatment of 50 cases of knee osteoarthritis with small acupotomy. Chinese Community Physician. 2020;36(7):2.

[8] Teichmann J, Lange U, Stracke H, Federlin K, Bretzel RG. Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis. Rheumatology International. 1999;18(4):137.

[9] Law J, Nauka PC, Nguyen A, Lefrancois D. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) associated with DPP-4 inhibitor. The American Journal of Medicine. 2021;134(7):e412-e414.

How to cite this paper

A Case Report and Literature Review of a 33-year-old Female with Youthful RS3PE Syndrome

How to cite this paper:  Chan Cai, Yinghua Li, Mammillan, Rong Yang, Yunchun Zhou. (2025) A Case Report and Literature Review of a 33-year-old Female with Youthful RS3PE Syndrome. International Journal of Clinical and Experimental Medicine Research9(1), 51-55.

DOI: http://dx.doi.org/10.26855/ijcemr.2025.01.010